Home / Peptide Database / Mazdutide
GLP-1R/GCGR DUAL AGONIST
Mazdutide
Mazdutide (IBI362) is a dual GLP-1 receptor and glucagon receptor agonist under clinical development by Innovent Biologics.olic data in Phase 3 trials.
Available strengths
10mg
1 of 1 rows in stock
Potency loss over time
Estimated potency retained (%) per storage condition. Hover the chart for details.
Freezer −20 °C
36+ mo
Stable · >95% potency
Fridge 4 °C
4-6 mo
In use · after recon
Room 20 °C
2-3 wks
Limited · moderate loss
Warm 37 °C+
<1 day
Critical · rapid degradation
⚠ A structural estimate, derived from each compound's sequence length, cyclisation and oxidation-, deamidation- and light-sensitive residues. Indicative only — not lab-measured per batch.
Time in body
No established terminal half-life. Human or animal pharmacokinetics for this compound are not published, so no clearance curve is shown — we don't model a curve from data that doesn't exist.
Strength 10mg1
| # | Suppliers | Price | €/mg | Price trend (6 months) | Purity | COA | Score ⓘ | |
|---|---|---|---|---|---|---|---|---|
| 1 |
 24P
| €139 | €13.9/mg | 99% | ✔ Liquilabs | Shop → |
Prices manually checked and updated monthly — source: publicly available supplier data. No affiliate links, no paid placement.
Mazdutide
Mechanism, evidence level, EU status and COA guidance per compound. No dosages, no protocols — that belongs with a doctor.